213 related articles for article (PubMed ID: 16639914)
1. P-100 in the treatment of Ménière's disease: a clinical study.
Franz B; van der Laan F
Int Tinnitus J; 2005; 11(2):146-9. PubMed ID: 16639914
[TBL] [Abstract][Full Text] [Related]
2. [Local overpressure treatment reduces vestibular symptoms in patients with Menière's disease--secondary publication. A clinically randomised multicenter double-blind placebo-controlled study].
Thomsen JC; Sass K; Odkvist L; Arlinger S
Ugeskr Laeger; 2006 Jan; 168(4):378-80. PubMed ID: 16436239
[TBL] [Abstract][Full Text] [Related]
3. Local pressure protocol, including Meniett, in the treatment of Ménière's disease: short-term results during the active stage.
Barbara M; Consagra C; Monini S; Nostro G; Harguindey A; Vestri A; Filipo R
Acta Otolaryngol; 2001 Dec; 121(8):939-44. PubMed ID: 11813899
[TBL] [Abstract][Full Text] [Related]
4. Immediate effects of middle ear pressure changes on the electrocochleographic recordings in patients with Menière's disease: a clinical placebo-controlled study.
Densert B; Densert O; Arlinger S; Sass K; Odkvist L
Am J Otol; 1997 Nov; 18(6):726-33. PubMed ID: 9391668
[TBL] [Abstract][Full Text] [Related]
5. Intermittent pressure therapy of intractable Ménière's disease using the Meniett device: a preliminary report.
Gates GA; Green JD
Laryngoscope; 2002 Aug; 112(8 Pt 1):1489-93. PubMed ID: 12172267
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Meniere's disease with the low-pressure pulse generator (Meniett device).
Gates GA
Expert Rev Med Devices; 2005 Sep; 2(5):533-7. PubMed ID: 16293064
[TBL] [Abstract][Full Text] [Related]
7. The effects of transtympanic micropressure treatment in people with unilateral Meniere's disease.
Gates GA; Green JD; Tucci DL; Telian SA
Arch Otolaryngol Head Neck Surg; 2004 Jun; 130(6):718-25. PubMed ID: 15210552
[TBL] [Abstract][Full Text] [Related]
8. [Middle ear overpressure with Meniett in Menière disease: indications, results at short and middle terms in 53 cases].
Faict H; Bouccara D
Rev Laryngol Otol Rhinol (Bord); 2007; 128(1-2):33-6. PubMed ID: 17633662
[TBL] [Abstract][Full Text] [Related]
9. The effect of the Meniett device in patients with Ménière's disease: long-term results.
Dornhoffer JL; King D
Otol Neurotol; 2008 Sep; 29(6):868-74. PubMed ID: 18617868
[TBL] [Abstract][Full Text] [Related]
10. Local overpressure treatment reduces vestibular symptoms in patients with Meniere's disease: a clinical, randomized, multicenter, double-blind, placebo-controlled study.
Thomsen J; Sass K; Odkvist L; Arlinger S
Otol Neurotol; 2005 Jan; 26(1):68-73. PubMed ID: 15699722
[TBL] [Abstract][Full Text] [Related]
11. Positive pressure therapy for Meniere's syndrome/disease with a Meniett device: a systematic review of randomised controlled trials.
Syed MI; Rutka JA; Hendry J; Browning GG
Clin Otolaryngol; 2015 Jun; 40(3):197-207. PubMed ID: 25346252
[TBL] [Abstract][Full Text] [Related]
12. Initial UK experience of patient satisfaction with the Meniett® device for Ménière's disease treatment.
Buchanan MA; Rai A; Prinsley PR
J Laryngol Otol; 2010 Oct; 124(10):1067-72. PubMed ID: 20537216
[TBL] [Abstract][Full Text] [Related]
13. Functional outcome of treatment of Ménière's disease with the Meniett pressure generator.
Stokroos R; Olvink MK; Hendrice N; Kingma H
Acta Otolaryngol; 2006 Mar; 126(3):254-8. PubMed ID: 16618650
[TBL] [Abstract][Full Text] [Related]
14. Meniett therapy: rescue treatment in severe drug-resistant Ménière's disease?
Boudewyns AN; Wuyts FL; Hoppenbrouwers M; Ketelslagers K; Vanspauwen R; Forton G; Van de Heyning PH
Acta Otolaryngol; 2005 Dec; 125(12):1283-9. PubMed ID: 16303675
[TBL] [Abstract][Full Text] [Related]
15. Meniere's disease and middle ear pressure: vestibular function after transtympanic tube placement.
Park JJ; Chen YS; Westhofen M
Acta Otolaryngol; 2009 Dec; 129(12):1408-13. PubMed ID: 19922090
[TBL] [Abstract][Full Text] [Related]
16. Meniett clinical trial: long-term follow-up.
Gates GA; Verrall A; Green JD; Tucci DL; Telian SA
Arch Otolaryngol Head Neck Surg; 2006 Dec; 132(12):1311-6. PubMed ID: 17178941
[TBL] [Abstract][Full Text] [Related]
17. The potential role of joint injury and eustachian tube dysfunction in the genesis of secondary Ménière's disease.
Franz B; Anderson C
Int Tinnitus J; 2007; 13(2):132-7. PubMed ID: 18229792
[TBL] [Abstract][Full Text] [Related]
18. Long-term effect of transtympanic intermittent pressure therapy using a tympanic membrane massage device for intractable meniere's disease and delayed endolymphatic hydrops.
Shojaku H; Takakura H; Asai M; Fujisaka M; Ueda N; Do TA; Tsubota M; Watanabe Y
Acta Otolaryngol; 2021 Nov; 141(11):977-983. PubMed ID: 34689678
[TBL] [Abstract][Full Text] [Related]
19. Intermittent pressure therapy of intractable Meniere's disease and delayed endolymphatic hydrops using the transtympanic membrane massage device: a preliminary report.
Watanabe Y; Shojaku H; Junicho M; Asai M; Fujisaka M; Takakura H; Tsubota M; Yasumura S
Acta Otolaryngol; 2011 Nov; 131(11):1178-86. PubMed ID: 21838607
[TBL] [Abstract][Full Text] [Related]
20. Meniere's attacks occur in the inner ear with excessive vasopressin type-2 receptors.
Kitahara T; Doi K; Maekawa C; Kizawa K; Horii A; Kubo T; Kiyama H
J Neuroendocrinol; 2008 Dec; 20(12):1295-300. PubMed ID: 19094077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
